France / Français
Researchers crack the code to muscle generation
In a new study, researchers from the University of Copenhagen have identified a protein that the body...
3 hours ago - Healthy Aging
Early natural menopause increases risk for lung diseases, death in women who smoke
In midlife and older smokers, natural menopause before age 45 years was associated with malignant and nonmalignant lung diseases and mortality, according to data published in...
5 hours ago - Healio - 2 articles
Disrupted nights during menopause cost women FIVE WEEKS' sleep every year, survey shows
Women lose five and a half weeks of sleep a year due to the menopause, a study has suggested. These women wake up on average 2.7 times a night and experience a variety of issues.
10 hours ago - Daily Mail
Episode 445 - Full Transcript
From podcast Podcast Sponsors Ginger for Healthy Ageing Antiaging
13 hours ago - Ben Greenfield Fitness
Glycoprotein GPNMB Is A Possible Biomarker For Parkinson'S Disease Risk
Computational, cell biological, and human tissue-based studies establish GPNMB as a risk gene and potential therapeutic target for Parkinson's Disease , researchers report.
1 day ago - News Medical - 2 articles
Study Identifies New Dementia Risk Genes Through Novel Testing Approach
A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy by using a...
1 day ago - News Medical - 2 articles
Therapeutic target for several metabolic diseases may help fight Alzheimer's disease
In the recent popular Korean TV series "The Light in Your Eyes," many viewers emphasized with the main character suffering from Alzheimer's disease.
1 day ago - News Medical
Lose Weight, Slow Knee OA Progression? New Study Suggests Yes
Declines in body mass index were linked with slower worsening of knee osteoarthritis , according to data from three large longitudinal cohort studies. With more than 6,000...
1 day ago - MedPageToday
FDA accepts new drug application for fezolinetant
The FDA accepted a new drug application from Astellas for fezolinetant, a nonhormonal drug for treating moderate to severe menopause-related vasomotor symptoms, according to a...
1 day ago - Healio
Q&A 445: The Best New Anti-Aging Compounds, Gut Healing Supplements, What Ben Would Do If He Got Cancer, The Worst Things For Fertility & Much More!
Have a question you'd like Ben to answer on the podcast?
1 day ago - Ben Greenfield Fitness
Free Registration
The headlines of Master Doctor
Researchers crack the code to muscle generation
In a new study, researchers from the University of Copenhagen have identified a protein that the body...
Disrupted nights during menopause cost women FIVE WEEKS' sleep every year...
Women lose five and a half weeks of sleep a year due to the menopause, a study has suggested. These women wake up on average 2.7 times a night and experience a variety of issues.
Episode 445 - Full Transcript
From podcast Podcast Sponsors Ginger for Healthy Ageing Antiaging
Therapeutic target for several metabolic diseases may help fight Alzheimer's...
In the recent popular Korean TV series "The Light in Your Eyes," many viewers emphasized with the main character suffering from Alzheimer's disease.
Lose Weight, Slow Knee OA Progression? New Study Suggests Yes
Declines in body mass index were linked with slower worsening of knee osteoarthritis , according to data from three large longitudinal cohort studies. With more than 6,000...
FDA accepts new drug application for fezolinetant
The FDA accepted a new drug application from Astellas for fezolinetant, a nonhormonal drug for treating moderate to severe menopause-related vasomotor symptoms, according to a...
Q&A 445: The Best New Anti-Aging Compounds, Gut Healing Supplements, What...
Have a question you'd like Ben to answer on the podcast?
Inflation Reduction Act Cuts Prescription Drug Costs for Older Adults
With the Inflation Reduction Act of 2022 signed into law on Aug. 16, millions of Medicare enrollees will be able to better afford their life-sustaining medications, and...
Denosumab biosimilar displays noninferiority in postmenopausal patients with...
A denosumab biosimilar candidate demonstrated noninferior efficacy to its reference product, with similar safety profile, in postmenopausal patients with osteoporosis...
Genetic links can help men with higher risk of prostate cancer get early...
A fifth of annual suspected UK prostate cancer referrals could be fast-tracked for investigation, while another 40 per cent could avoid referral and invasive biopsies if...